The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort

…, AM Huber, N Shiff, G Boire, R Scuccimarri… - Annals of the …, 2015 - ard.bmj.com
Objective To describe clinical outcomes of juvenile idiopathic arthritis (JIA) in a prospective
inception cohort of children managed with contemporary treatments. Methods Children newly …

Incident vertebral fractures among children with rheumatic disorders 12 months after glucocorticoid initiation: a national observational study

…, AM Huber, DA Cabral, R Scuccimarri… - Arthritis care & …, 2012 - Wiley Online Library
Objective To determine the frequency of incident vertebral fractures (IVF) 12 months after
glucocorticoid (GC) initiation in children with rheumatic diseases and to identify children at …

Consensus treatments for moderate juvenile dermatomyositis: beyond the first two months. Results of the second Childhood Arthritis and Rheumatology Research …

…, B Shaham, H Schmeling, R Scuccimarri… - Arthritis care & …, 2012 - Wiley Online Library
Objective To use consensus methods and the considerable expertise contained within the
Childhood Arthritis and Rheumatology Research Alliance (CARRA) organization to extend …

Early outcomes and improvement of patients with juvenile idiopathic arthritis enrolled in a Canadian multicenter inception cohort

…, N Johnson, J Dorval, R Scuccimarri… - Arthritis care & …, 2010 - Wiley Online Library
Objective To determine early outcomes and early improvements in a prospective inception
cohort of children with juvenile idiopathic arthritis (JIA) treated with current standard therapies…

Treatment approaches to juvenile dermatomyositis (JDM) across North America: the childhood arthritis and rheumatology research alliance (CARRA) JDM treatment …

…, S Ota, C Pilkington, AM Reed, R Scuccimarri… - The Journal of …, 2010 - jrheum.org
Objective. There are a number of different approaches to the initial treatment of juvenile
dermatomyositis (JDM). We assessed the therapeutic approaches of North American pediatric …

Incident vertebral fractures and risk factors in the first three years following glucocorticoid initiation among pediatric patients with rheumatic disorders

…, J Ma, M Taljaard, J Roth, R Scuccimarri… - Journal of Bone and …, 2015 - academic.oup.com
Vertebral fractures are an important yet underrecognized manifestation of osteoporosis in
children with chronic, glucocorticoid‐treated illnesses. Our goal was to determine the …

The risk and nature of flares in juvenile idiopathic arthritis: results from the ReACCh-Out cohort

…, DM Levy, E Stringer, R Scuccimarri… - Annals of the …, 2016 - ard.bmj.com
Objective To describe probabilities and characteristics of disease flares in children with juvenile
idiopathic arthritis (JIA) and to identify clinical features associated with an increased risk …

Predictors of early inactive disease in a juvenile idiopathic arthritis cohort: results of a Canadian multicenter, prospective inception cohort study

…, AM Huber, P Miettunen, R Scuccimarri… - Arthritis Care & …, 2009 - Wiley Online Library
Objective To determine early predictors of 6‐month outcomes in a prospective cohort of
patients with juvenile idiopathic arthritis (JIA). Methods Patients selected were those enrolled in …

Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children: a propensity-weighted cohort study

…, CM Biggs, A Lopez, R Scuccimarri… - The Lancet …, 2023 - thelancet.com
Background Multisystem inflammatory syndrome in children (MIS-C), a hyperinflammatory
condition associated with SARS-CoV-2 infection, has emerged as a serious illness in children …

Aspirin dose and prevention of coronary abnormalities in Kawasaki disease

…, BW McCrindle, DG Human, R Scuccimarri - …, 2017 - publications.aap.org
BACKGROUND: Acetylsalicylic acid (ASA) is part of the recommended treatment of Kawasaki
disease (KD). Controversies remain regarding the optimal dose of ASA to be used. We …